has been cited by the following article(s):
[1]
|
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis,
Docking Study, and Structure Activity Relationship
Anti-Cancer Agents in Medicinal Chemistry,
2023
DOI:10.2174/1871520623666230227153449
|
|
|
[2]
|
Novel and Latest Computational and Development of Anticancer Cancer
Onco Therapeutics,
2022
DOI:10.1615/OncoTherap.2022044866
|
|
|
[3]
|
Novel and Latest Computational and Development of Anticancer Cancer
Onco Therapeutics,
2022
DOI:10.1615/OncoTherap.2022044866
|
|
|